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To maintain genomic integrity, a cell must utilize multiple mechanisms to protect its DNA from the
damage generated by environmental agents or DNA metabolism. SUMO (small ubiquitin-like mod-
iﬁer) can regulate protein stability, protein cellular location, and protein–protein interactions. In
this review, we summarize the current understanding of the roles of SUMOylation and de-SUMOy-
lation in DNA damage response (DDR) and DNA repair with a speciﬁc focus on the role of RPA
SUMOylation in homologous recombination (HR).
 2011 Federation of European Biochemical Societies. Published by Elsevier B.V.1. Introduction
DNA damage response (DDR) and DNA repair are important
mechanisms that protect genomic integrity from DNA damage
generated by environmental agents or DNA metabolism [1,2]. They
are precisely regulated by the post-translational modiﬁcations of
target proteins, including phosphorylation, ubiquitination, methyl-
ation, acetylation and protein-based modiﬁcation. The ﬁrst
protein-based modiﬁcation to be described was ubiquitin [3–6].
Over past several years modiﬁcation of SUMO (small ubiquitin-like
modiﬁer), one member of UBLs (ubiquitin-like proteins), has
emerged as a critical factor in multiple biological processes such
as DNA transcription, DNA replication, and the events following
DNA damage [7–10]. In this review, we will discuss the current
understanding of the roles of several critical components in the
cycle of SUMOylation and de-SUMOylation and recent develop-
ments of SUMOylation and de-SUMOylation in DDR or DNA repair.
More speciﬁcally, we will focus on the role of RPA SUMOylation in
homologous recombination (HR) and roles of SENPs (SUMO-spe-
ciﬁc proteases) in response to DNA damage stress.al Societies. Published by Elsevier
t. Luke’s Episcopal Hospital,
).2. SUMOylation and de-SUMOylation
There are more than a dozen UBLs in mammals [11,12]. The
conjugation of ubiquitin or UBLs to lysine side chains in target pro-
teins is a protein-based posttranslational modiﬁcation, which
greatly confers the functional and dynamic diversities of modiﬁed
proteins. Since the discovery of SUMO 14 years ago, its roles in dif-
ferent biological processes are extensively investigated [7–10].
Budding yeast expresses one SUMO protein (Smt3p). Mammalian
cells have four SUMO paralogs: SUMO-1 (also called Sentrin 1);
SUMO-2 (also known as Sentrin 3) and SUMO-3 (also known as
Sentrin 2) [7]. The matured SUMO-2 and SUMO-3 are 95% identi-
cal to each other and are 45% identical in sequence with SUMO-1.
SUMO-4 is probably not conjugated under physiological condi-
tions, so its biological role is unclear [13].
SUMO conjugation is regulated through an enzyme-controlled
cycle. Like most other UBLs, SUMO paralogs are synthesized as pre-
cursors that must be processed to reveal the C-terminal di-glycine
motif to become the matured forms. Next, the matured SUMOs are
activated by a SUMO-activating enzyme (E1), a heterodimer con-
taining SAE1 (SUMO-activating enzyme subunit 1) and SAE2,
transferred by a SUMO-conjugating enzyme (E2), UBC9, to sub-
strate to form an isopeptide bond between the C-terminal carboxy
group of SUMO and the e-amino group of lysine in the substrate
protein that is usually with the help of a SUMO protein ligase
(E3) [7,14]. Typically, lysine residues modiﬁed by SUMO are found
within a SUMO modiﬁcation consensus motif, wKXE (where w is aB.V. Open access under CC BY-NC-ND license.
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cation at non-consensus sites has been reported [15,16]. SUMO-2
and SUMO-3, like Smt3p, can form chains in vitro and in vivo, pri-
marily through a conserved lysine (Lys15 in Smt3p, Lys11 in
SUMO-2 or SUMO-3) [17–19]. SUMO conjugation is usually
short-lived and SUMOylated proteins will be rapidly deconjugated
by the SUMO/Sentrin-speciﬁc proteases (SENPs) [9,20].
Six SENPs have been identiﬁed. SENP1, SENP2, SENP3, and
SENP5 are more closely related to the yeast ULP1, whereas SENP6
and SENP7 are related to ULP2 [9]. SENP1 and SENP2 process both
C-terminal hydrolysis and isopeptidase activity in mammalian
cells [9,20]. SENP1 is more efﬁcient at processing both SUMO-1
and SUMO-2 than SUMO-3 [21]. In contrast, SENP2 preferentially
processes SUMO-2 among SUMO paralogs. Structure analysis indi-
cates that two residues at the C-terminal side of the cleavage site
make a signiﬁcant contribution to SUMO process by SENP1 [21].
These sequences are His-Ser in SUMO-1, Val-Tyr in SUMO-2, and
Val-Pro in SUMO-3. They also likely determine the efﬁciency of
SENP2 activity [22]. SENP1-(415–643) deconjugates SUMO-1-con-
jugated and SUMO-2-conjugated RanGAP1 indistinguishably
in vitro [21], but it can discriminate between SUMO-1-conjugated
RanGAP1 and Sp100 [23], suggesting that the structure of its target
proteins also impacts the isopeptidase activity of SENP1. SENP2
deconjugates SUMO-1-conjugated RanGAP1 more efﬁciently than
it does SUMO-2-conjugated in vitro, in accordance with its higher
hydrolytic activity in processing SUMO-2 [22]. The isopeptidase
activity of SENP1 and SENP2 seems to be related to their interact-
ing interface with SUMOs. During deconjugation of RanGAP1–
SUMO-2/3 and RanGAP1–SUMO-1, there is an increased interface
between SUMO-2/3 and SENP2 corresponding to the preferential
deconjugation of RanGAP1–SUMO-2/3 by SENP2 compared with
that of RanGAP1–SUMO-1 [22]. However, the interfaces between
SUMOs and SENP1 are essentially same, corresponding to the
indistinguishable capability of SENP1 to deconjugate both Ran-
GAP1–SUMO-1 and RanGAP1–SUMO-2 [21]. In addition, the cata-
lytic interface of SENP1 and SENP2 appears to be favorable for
the lysine side-chain, with higher degrees of freedom than the
more-rigid peptide extension of unprocessed SUMOs. This explains
why the isopeptidase activities of both SENP1 and SENP2 are much
stronger than their C-terminal hydrolase activity [21,22]. Com-
pared with SENP1 and SENP2, SENP5 efﬁciently processes the pre-
cursor of SUMO-3 only [24,25]. SENP6 and SENP7 show very low
processing activity [26,27]. SENP3 and SENP5 are more active in
deconjugating SUMO-2/3-conjugated targets than SUMO-1-con-
taining species [24,25]. In yeast, ULP2 deletion causes an accumu-
lation of high-molecular-weight conjugated species of Smt3p. In
mammalian cells, SENP6 and SENP7, the members of ULP2 family,
show stronger activity on poly-SUMO-2/3 chain than on single
SUMO moieties and SUMO-1 chains [26,27]. The structure of
SENP7 is unique compared to other well characterized family
members such as SENP1, SENP2, and ULP1. The deletion of a dis-
tinct region in SENP7, which appears to be in a suitable position
to explain its speciﬁcity via interactions with an extended SUMO
chain, had no effect on the activities of SENP7, indicating either
that the link between the SENP7’s structure and its speciﬁc activity
on poly-SUMO-2/3 chain is not clear, or that high poly-SUMO2/3
chain deconjugation activities observed for SENP6 and SENP7
may simply reﬂect a preference for ﬂexible isopeptide linked sub-
strates [27]. It is also unclear whether or not that SENP6 and SENP7
functions redundantly in vivo.
3. SUMOylation in DDR
The cascade ofDDR signaling is reﬂectedby thatDDRproteins are
orderly recruited and function at DNA damage sites that are modu-lated by the post-translation modiﬁcations, including phosphoryla-
tion, acetylation, methylation, ubiquitination and poly(ADP-
ribosylation) [2,28–31]. Roles of ATM and ATR kinases have been
extensively studied compared to DNA-PK that primarily regulates
a smaller group of proteins involved in DSB end joining. In response
to DSBs, PARP1 initiates the recruitment of the MRN/ATM complex
at DSBs [32,33]. Next, activation of the ATM byMRN and TIP60 trig-
gers a signaling orchestra involving in the phosphorylation of CHK2,
p53andH2AX [34–36]. Thepresenceofc-H2AX is essential for accu-
mulation and retention of signaling and repair factors at the break,
which promotes an ordered recruitment of MDC1 [37–39], RNF8
[40–42], RNF168 [43], BRCA1, and 53BP1 [44].
In response to replication stress, the accumulation of RPA-coated
ssDNA regions at stalled replication fork, recruits the ATR/ATRIP and
the RAD17/RFC2–5 complexes [45]. Next, loading of the 9-1-1 com-
plex by RAD17/RFC2–5 together with the 9-1-1-associated proteins
[46,47] results in the activation of the ATR signaling cascade and
CHK1 phosphorylation. Through these signal transduction path-
ways, DDR channels physiological processes to different directions,
such undergo apoptosis, enter senescence, activate heightened im-
mune surveillance, as well as initiate DNA repair [48–50].
Recently, Morris et al. and Galanty et al. showed that SUMO,
UBC9, the SUMO-ligase enzymes, PIAS1 and PIAS4, and two of their
substrates, BRCA1 and 53BP1, relocated to c-H2AX foci after DNA
damage. Additionally, they found that PIAS4 regulated events corre-
latedwith SUMO-1 and 53BP1modiﬁcation, and PIAS1with SUMO-
2/3 and BRCA1 modiﬁcation. Moreover, Morris et al. identiﬁed two
consensus SUMO-conjugation sites in BRCA1 and documented their
important roles for regulating BRCA1’s ubiquitin ligase activity.
Notably, they observed that depletion of PIAS1 and PIAS4 caused
the defect of RNF8/HERC2/RNF168-dependent ubiquitination and
accumulation of subsequent proteins at DNA damage sites. Consis-
tent with this, PIAS depleted cells impaired kinetics of DNA repair
and enhanced sensitivity to genotoxic insults [51,52].
Given the effects of PIAS1/4 depletion on the activities of RNF8/
RNA168, RNF8/RNF168 complex could also be regulated by
SUMOylation. Could more SUMO substrates be involved in the
pathway of DDR signaling? In fact, many proteins in DDR signaling
cascade were reported to be SUMOylated. In response to heat
shock, PIASy-promoted poly-SUMOylation of PARP1 induces
RNF4-mediated ubiquitination of PARP1, which decreases PARP1
stability and regulates its transcription function [53]. In addition,
SUMOylation of PARP1 does not affect its ADP-ribosylation activity
in vitro, but restrains its transcriptional coactivator function by
abrogating its p300-mediated acetylation [54] and alters the
capacity of PARP1 to modify other chromatin-associated proteins
[55]. Therefore, SUMOylation can modulate PARP1 via several dif-
ferent mechanisms involving in altering protein degradation and
affecting other modiﬁcations. Apart from PARP1, in response to
UV, the site-speciﬁc SUMOylation of TIP60 at lysines 430 and
451 initiates its relocation from nucleoplasm to the promyelocytic
leukemia (PML) body and the overexpression of non-SUMOylatable
mutant abrogates the p53-dependent DNA damage response,
revealing that the SUMOylation of TIP60 augments its acetyltrans-
ferase activity in UV-irradiated DNA damage response [56]. In
addition, both RNF168 and RAP80 have been shown to be SUMOy-
lated [57,58]. It will be interesting to test if these SUMOylations
function in DDR signaling. Roles of SUMOylated p53, the well
known effector in DDR signaling, have been extensively studied
and excellently reviewed in several publications [59,60].
4. SUMOylation in DNA repair
SUMOylation has been involved in many DNA repaired path-
ways. For example, SUMOylation affects the cellular localization
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of DNA glycosylases in base excision repair (BER) [61–63]; XPC
SUMOylation increases its stability and decreases its afﬁnity for
the formed complex of nucleotide excision repair (NER) for reutili-
zation [64] ; the non-SUMOylable mutant of XRCC4, a non-homol-
ogous end joining (NHEJ)-related factor, cannot be translocated
from cytoplasm to nucleus, leading to radiation sensitivity and fail-
ure to complete V(D)J recombination [65]. In this review, we will
focus on role of SUMOylation in HR.
HR is initiated by the MRE11–RAD50–NBS1 (MRN) complex
that stabilizes DNA ends, initiates the DNA resection, and promotes
the recruitment of ATM [66]. DNA end resection is carried out by
CtIP [67]. In S and G2, CtIP associates with BRCA1, which facilitates
DNA end processing [67]. In addition, more other protein factors
are also involved in the entire process of DSB resection [68–70].
Next, the single strand DNA-binding protein replication protein A
(RPA) binds to the ssDNA overhangs, and RAD51/RAD52 are then
recruited to DSBs. Both RPA and RAD52 help load RAD51 onto
ssDNA to form nucleoprotein ﬁlaments which search for the
homologous duplex DNA in the undamaged sister chromatid to
facilitate strand invasion that forms D loop [71]. In yeast, RAD52
is an essential recombination-mediator, but MmRAD52 null mice
are viable and display no abnormalities in fertility and in develop-
ment of the immune system [72].MmRAD52/ ES cells are also not
hypersensitive to agents that induce DSBs. Therefore, the presence
of genes functionally related to MmRAD52 can partially compen-
sate for the absence of MmRAD52 protein [73]. The potential can-
didates are human RAD51 paralogs or BRCA2 [73]. D loop could be
dissembled by RTEL to generate non-crossover [74]. The newly
synthesized fragments ends joined by DNA ligases could form dou-
ble Holliday Junctions (dHJs) [71]. HJ intermediates could be dis-
solved by the BLM/TOPOIII complex or cleaved by the
endonucleases GEN1, MUS81/EME1, or SLX1/SLX4 to generate
either crossover or non-crossover products [75–77].
PIAS1 or PIAS4 depletion impairs RPA accumulation in laser-
lines. Consistent with this ﬁnding and the involvement of RPA-
coated single strand DNA in homologous recombination, PIAS1 or
PIAS4 depletion reduced homologous recombination [51,52]. Both
RAD51 and RAD52 have been shown to interact with UBC9 and
SUMO directly [78–82]. Overexpression of both SUMO and non-
conjugated SUMO decrease radioresistance by down-regulating
DSB-induced HR [83]. While we and other group found that
SUMOylation mutant proteins inhibit HR [81,82]. This controversy
may be related to artiﬁcially overexpressed SUMO that can en-
hance numerous proteins’ SUMOylation and affect HR indirectly.
In line with our ﬁndings, defect of UBC9 or MMS21 causes the sig-
niﬁcant disruption of RAD51 intracellular trafﬁcking, resulting in
markedly inhibition of DNA damage-induced RAD51 nuclear foci
[84] or the hyperactivation of ATM/ATR signaling pathways, result-
ing in a consequent DNA damage-induced apoptosis [85].
Recently, role of SUMO in proteins involving in resolution of
dHJs has also been shown. As we described before, the BLM/TOPO-
III complex can dissolve dHJs at the late stage of in HR. BLM inter-
acts directly with the RAD51 and in vitro it can displace RAD51
from ssDNA and unwind the invading DNA strand of a D-loop
formed by RAD51 [86]. Interestingly, BLM also collaborates with
exonucleases that process DSBs to generate ssDNA for a formation
of RAD51 ﬁlament [87]. Thus, BLM has both anti- and pro-recom-
binogenic functions in HR, raising an interesting question how
these different functions of BLM in HR are controlled. SUMOylation
of BLM had been shown to regulate BLM’s cellular distribution [88].
Further studies by Ouyang et al. showed that HU treatment failed
to induce SCEs (sister chromatid exchanges) in non-SUMOylable
BLM cells compared to normal BLM cells due to impaired RAD51
localization to HU-induced repair foci. They also found that
in vitro RAD51 directly interacts with SUMO and that SUMOylationenhances the binding of RAD51 to BLM. The data demonstrates
that SUMOylation switches BLM’s pro- and anti-recombinogenic
functions in HR; alternatively, BLM SUMOylation relieves its inhib-
itory effects on HR, and promotes RAD51 function. Additionally,
SUMOylation also regulates the transport of Werner’s helicase
(WRN) [89,90], another member of the RecQ family of DNA heli-
cases that partially co-localizes with DNA repair proteins, such as
RAD51 and RAD52, and may be involved in several nuclear func-
tions, such as HR, restoration of stalled replication forks, repair of
DNA strand breaks, and telomere maintenance.
HR mechanism also involves in maintaining telomere length in
ALT (alternative lengthening of telomeres) cells [91]. Telomeres are
repetitive DNA elements, involving the repeat sequence TTAGGG in
humans, which comprise 5–15 kilobases at the ends of chromo-
somes [92]. Telomeres are shortened due to the end-replication
problem of the lagging strand and critically short telomere induces
cellular senescence in mammalian cells [93,94]. The transcriptional
upregulation of telomerase is the major mechanism to overcome
this replication-mediated defect. Some cancer cells rely on an
ALT mechanism to elongate telomeres due to the defect of up-reg-
ulating telomerase, which facilitates telomere elongation by
recruiting telomerase into nuclear PML bodies and then initiating
HR by the participation of HR proteins [95]. The Shelterin/Telo-
some complex, consisting of six core proteins, TRF1, TRF2, TIN2,
TPP1, RAP1, and POT1, binds to telomeric DNA and prevents it from
being recognized as DSBs [96]. SUMOylation of TRF1, TRF2, TIN2,
and RAP1 is enhanced by MMS21 [97]. Inhibition of MMS21 blocks
recruitment of telomeres to APBs (ALT-associated promyelocytic
leukemia nuclear bodies). It is therefore proposed that SUMOyla-
tion of the Shelterin/Telosome complex could promote the relocal-
ization of telomerase to PML bodies due to the high afﬁnity of
proteins within PML bodies for SUMO [97].
Roles of SUMO in HR have been extensively studied in yeast.
The ubc9 cells exhibit a RAD51-dependent accumulation of cruci-
form structures in response to replication stress, indicating an
important role of SUMOylation in resolution of recombination
intermediates during DNA replication [98]. Consistently, UBC9
and SUMOylated PCNA are essential for RAD18-MMS2-mediated
damage-bypass through SCJs (sister chromatid junctions), a
RAD51-dependent recombination event [99]. SUMO has also been
demonstrated to impact yeast RAD52 from different aspects, such
as enhances its stability, decreases its binding afﬁnity to DNA,
and promotes repair within regions of repetitive DNA [100–102].
In addition, Ohuchi et al. reported that SUMOylation of RAD52 oc-
curs only in the S phase by induction of MMS and is important for
MMS-induced interchromosomal homologous recombination,
which may be led by the RAD52 SUMOylation-mediated an efﬁ-
cient recruitment of RAD51 [103]. However, no evidence shows
that mammalian RAD52 could be SUMOylated in response to
DNA damage, which is consistent with the case of PNCA that we
discuss elsewhere and that a set of important proteins involved
in HR events, lack clear homologs in yeast, such as the tumor-sup-
pressor and cell cycle proteins p53, BRCA1 and BRCA2 [104]. Thus,
the roles of SUMO in HR might be variable in different species from
an evolutionary point.5. RPA-SUMOylation in HR
RPA, the main eukaryotic ssDNA binding protein complex, con-
sists of three subunits, RPA1 (RPA70), RPA2 (RPA32), and RPA3
(RPA14). RPA70 is the major ssDNA binding subunit and is involved
primarily in interactions with other DNA metabolism proteins
[105,106]. The hyper-phosphorylation of RPA32 may redirect RPA
from DNA replication to DNA repair [107]. RPA14 is required for
stable heterotrimer formation [105,108]. We ﬁrst noted the
RPA SUMO-2/3 Rad51
Fig. 1. Role of RPA SUMOylation in DNA repair. Single strand DNA is coated by RPA that is SUMOylated by an unknown E3. RPA70 SUMOylation serves as a HR mediator to
facilitate recruitment of RAD51 to initiate strand invasion. This model does not show the roles of other HR mediators.
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knockdown cells reveal the signiﬁcant phenotype of DDR, includ-
ing the appearance of c-H2AX foci, enhanced phosphorylation of
CHK1 Ser-345 and CHK2 Thr-68 and defective cell cycle progres-
sion in both S and G2/M phases. In addition, SENP6-knockdown in-
duces the co-localization of RPA70 and SUMO-2/3 at many
punctate foci. These observations therefore led us to examine the
biological relevance between RPA70 SUMOylation and DNA dam-
age. Indeed, RPA70 can be modiﬁed in vivo on its lysine residues
449 and K577 with K449 being the major site of SUMOylation
and RPA70 SUMOylation is augmented by replication-mediated
DSB. Endogenous RPA70 is modiﬁed by SUMO-2/3. The major form
of SUMOylated RPA70 is di-SUMOylated RPA70 that is also induced
by heat shock [58]. Consistent with the observation from Ellis’
group [82], we also found that RAD51 directly interacts with SU-
MOs in vitro. Importantly, SUMOylation enhances the binding of
RAD51 to RPA70 and facilitates the formation of RAD51 ﬁlament
in vitro; RPA70(DSUMO) delays formation of RAD51 foci and inhib-
its HR events in vivo. We therefore propose that RPA70 SUMOyla-
tion may serve as HR mediator to facilitate recruitment of RAD51
to the DNA damage foci to initiate DNA repair through HR
(Fig. 1). It will be interesting to study if RPA SUMOylation also
functions in other DNA repair pathways, what the E3 for RPA70
is, and what the interplay is between SUMOylation and phosphor-
ylation in RPA complex.
The functional connection between SUMOylated PCNA and HR
is well established in budding yeast. PCNA SUMOylation recruits
Srs2 through a conserved SUMO-interaction motif in its carboxy-
terminus to prevent unscheduled recombination events at replica-
tion fork [10]. We again didn’t observe SUMOylation of PCNA in our
experiment. Although the failure to detect PCNA SUMOylation in
mammalian cells or even in ﬁssion yeast is no proof for its absence,
the action of SUMO on PCNA is very likely limited to the budding
yeast system, because no sequence or function related helicase is
found to exert as Srs2 on the RAD6 pathway [10]. Two subunits
of yeast RPA, RFA1 and RFA2, are also sumoylated in a SLX5–
SLX8-dependent manner after MMS treatment [109]. Since SLX5–
SLX8-dependent sumoylation disfavors SSA (single-strand anneal-
ing) and RAD51-independent BIR (break-induced replication)
[109]. The studies that address the functions of RFA1, RFA2 in
the RAD51-dependent repair processes by mapping and mutating
the SUMOylation sites will be interesting.
6. SENPs in the response to DNA damage stress
The ulp2D cells are permanently arrested as large-budded cells
regardless of whether the DNA DSB was repairable or not, and ex-
hibit wildtype RAD53 phosphorylation and dephosphorylation
kinetics. The induction of a non-repairable DNA DSB causes
approximate 50% ulp2D cells arrested in metaphase and in post-
metaphase, respectively, which depends on checkpoint proteins,
such as MEC1, RAD53, DUN1, or PDS1. These evidences suggest
that ULP2 functions after the termination of DNA damage check-
point and lead to propose that ULP2 restarts the cell cycle and
may also be required during a later stage of mitosis to promotesuccessful spindle development though its unknown substrates
[110,111].
Knocking down SENP6, a member of ULP2 family in mammals,
actives both CHK1 and CHK2 suggesting that SENP6 does not affect
upstream of DDR, which is consistent with the observations that
formations of c-H2AX and RPA foci are still available after deletion
of SENP6 [81]. In terms of DNA repair, SENP6-knockdown increases
SCE and does not inhibit formation of RAD51 foci, indicating that
SENP6 has minor effect at the early stage of HR [81]. In actuality,
SENP6 is an editor of SUMO polychain induced by different stres-
ses. Thus, SENP6 most likely functions at terminal stage of DNA
damage singling pathway for cell to restart its normal processes.
Both SENP1 and SENP2 regulate p53 in response to DNA dam-
age. Knocking down SENP1 by siRNA reduces p53-dependent
apoptosis through SIRT1 SUMOylation [112]. An isoform of SENP2
not only associates with MDM2 but also modulates its SUMO con-
jugation of MDM2 that prevents its self-ubiquitination and in-
creases its ability to ubiquitinate p53 [113]. DNA damage
stresses also regulate activities of SENPs. UV and H2O2 promote
the association of SENP1 with its substrate, SIRT1 to reduce p53-
dependent apoptosis [112]. H2O2 inhibits the activity of SENP1
by inducing the formation of an intermolecular disulﬁde linkage
between Cys-603 and Cys-613 [114]. This reversible modiﬁcation
has also been observed in the SUMO E1 subunit UBA2, E2-conju-
gating enzyme UBC9, and ULP1 [114]. Additionally, in presence
of exogenous SUMO-1, doxorubicin stimulates ATM-dependent
Ser-824 phosphorylation of KAP1 and represses its SUMOylation
through SENP1 [115]. It will be interesting to deﬁne if this phos-
phorylation plays a role in recruitment of SENP1. Moreover, oxida-
tive stress also induces the interaction between SENP3 and HSP90
that blocks ubiquitin-mediated proteasomal degradation through
impairing the E3 ligase function of CHIP [116].7. Conclusion and perspectives
The ﬁndings cited in this review suggest that SUMOylation and
de-SUMOylation play important roles in regulating of DNA dam-
age-induced events, including DDR and DNA repair. It is obvious
that much is not known about how DNA damage signaling regu-
lates several critical components in SUMO pathway. For instance,
is SUMO-E1 also involved the events in response to DNA damage?
How does DDR signaling direct UBC9 and SUMO E3 ligases to func-
tion in damage sites? How do different SENPs play their roles in re-
sponse to different DNA damage stresses? Clinically, there have
been two physical abnormalities related to the translocation of
the SENP gene. Translocation of SENP1 generates SENP1–MESDC2
[117], causing a form of sacrococcygeal teratoma; SENP6 is fused
to TBCA1 during T-cell lymphoma, thus linking to developmental
delay and recurrent infections [118]. In addition, overexpressed
SENP1 has been found in prostate cancer [119]. Moreover, in-
creased expression of UBC9 and PIASs has also noted in cancers
[120,121]. Thus, further exploration in this ﬁeld will identify po-
tential new approaches to both prevention and treatment of hu-
man diseases.
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